Lexology October 18, 2024
State-level oversight of M&A and other strategic transactions involving healthcare is continuing to expand into new markets and impact growth strategies.
The interest and need for healthcare services transactions in the United States continues, as providers, payors, investors, and others develop and adapt to new delivery models aimed at addressing systemic problems related to access, quality, outcomes, competition, and cost. New collaborations between providers, payors, and strategic partners, along with access to private capital, have, in significant part, driven the reconfiguration.
Over the last 15 years, the US antitrust regulatory landscape has evolved dramatically, with heightened federal government attention on merger activity in the healthcare space. Recently, this scrutiny has led to an expansion in state-level regulatory oversight of healthcare...
Today's Sponsors
Today's Sponsor